SS

Sanjay Singh

Active Director Director DIN 10556831
DIN 10556831 First appointment Mar 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Singh

Data last updated:

Sanjay Singh is a Director at Nbs Pharmaceticals Private Limited (since 2024) and Director at Omaansh Foundation (since 2024). The companies operate in Pharma.

DIN 10556831
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nbs Pharmaceticals Private Limited U46497MH2024PTC428008
Director29 Jun 20242024Active
Omaansh Foundation U85500UP2024NPL200106
Director28 Mar 20242024Active

Board colleagues of Sanjay Singh

Directorship timeline

Open interactive timeline →
Nbs Pharmaceticals Private Limited
Omaansh Foundation
Premium access

Shareholding and investment profile for Sanjay Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Singh

Sanjay Singh currently holds 2 directorships: Nbs Pharmaceticals Private Limited (Director, since 29 Jun 2024); Omaansh Foundation (Director, since 28 Mar 2024).

Sanjay Singh was first appointed on 28 Mar 2024 as Director at Omaansh Foundation.

The current boards of Sanjay Singh's companies include Bhupendra Pratap Singh (Nbs Pharmaceticals Private Limited), Neeta Bhupendra Singh (Nbs Pharmaceticals Private Limited), Deep Shikha Singh (Omaansh Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available